covid-19 UpdatesMarch 2022 – The Sickle Cell Disease Association of America’s Medical and Research Advisory Committee notes that news about COVID-19 continues to emerge. Monitor your state or local health department for more information. Below are some updates and suggestions for individuals with sickle cell disease. Several studies have examined the effects of COVID-19 infection in individuals in the sickle cell community and shown concerning results to include: Click here to read the full article, including MARAC recommendation. The Centers for Disease Control and Prevention (CDC) lists sickle cell disease (SCD) as one of the populations vulnerable to severe COVID-19. With this in mind, the Sickle Cell Disease Association of America - Mobile Chapter, Inc. (SCDAA-MC) wants to provide its clients with as much information possible for them to make the best decision for their individual health.
Based on current information, Sickle Cell Disease Association of America (SCDAA)recommends that people with sickle cell disease receive COVID-19 vaccination. Read the Special Statement from SCDAA's Medical and Research Advisory Committee These are some additional COVID-19 resources:
SCDAA-MC encourages you to reach out to your doctor to ask questions and get advice about your individual case. |